YMYasu S. Morita

Yasu S. Morita

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yasu S. Morita has a total of 249 co-authors. Here are the top co-authors by number of shared publications:

  • M. Sloan Siegrist

    University of Massachusetts Amherst

    12 shared publications
  • Ian L. Sparks

    Department of Microbiology, University of Massachusetts Amherst

    9 shared publications
  • Taroh Kinoshita

    Department of Immunoregulation, Research Institute for Microbial Diseases, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan

    9 shared publications
  • Malavika Prithviraj

    Department of Microbiology, University of Massachusetts, Amherst, MA, USA

    8 shared publications
  • Yusuke Maeda

    Laboratory of Immunoglycobiology, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan

    8 shared publications
  • Helen Billman-Jacobe

    Asia Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, and National Centre for Antimicrobial Stewardship, University of Melbourne, Parkville, VIC 3010, Australia

    7 shared publications

Latest Publications

  • Open Access

    ag85A loss promotes free mycolate accumulation and sensitizes plasma membrane domain to disruption

    by Takehiro Kado, Shivangi, Paige H. Bosworth, Jake Jordan, Joel S. Freundlich, M. Sloan Siegrist, Yasu S. Morita

    The mycomembrane of mycobacteria, which is composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress; however, its underlying synthesis mechanisms remain incompletely understood. This study investigated the role of the mycolyltransferase Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using ∆ ag85A deletion mutants, we combined microscopy, subcellular fractionation, mass spectrometry, and lipid analysis to evaluate changes in membrane structure, intracellular chemical accumulation, and lipid composition. The deletion of ag85A led to destabilization of the plasma membrane domain, increased chemical accumulation, and altered cell envelope lipid compositions. Consistent with prior studies, Δ ag85A accumulated mycolates, specifically in the free lipid pool rather than in the covalently linked cell wall fractions. In addition, the accumulation of an uncharacterized glycolipid species was absent or reduced in the wild-type and complemented strains; these findings indicate that Ag85A loss alters the distributions of mycolic acid-containing lipids and is associated with destabilization of the plasma membrane domain, highlighting a functional link between the processes of lipids and plasma membrane architecture. IMPORTANCE: The unique cell envelope of mycobacteria plays a vital role in survival by protecting against immune responses and antibiotic treatments. In this study, we examined the consequences of deleting ag85A , a well-characterized mycolyltransferase that contributes to the assembly of the mycomembrane lipid layer. In addition to known phenotypes, such as increased drug sensitivity and disrupted biofilm formation, our data reveal alterations in membrane-associated lipid distributions and suggest a possible link between membrane synthesis and plasma membrane organization. These findings provide new insight into the broader cellular impact of Ag85A loss and suggest avenues for further investigation into how lipid biosynthesis interfaces with membrane architecture. Understanding this relationship may inform new therapeutic strategies that destabilize the protective envelope of pathogenic mycobacteria.


  • Overexpression of a Gene That Modulates Cyclic‐di‐GMP Enhances Granulation in Mycobacterium smegmatis

    by Tiffany Lam, Samantha J. Belculfine, Kate N. Gregory, Joseph G. Gikonyo, Jeffrey J. Kane, Chul Park, Yasu S. Morita

    Granulation is a complex microbial‐aggregation process essential for forming aerobic granular sludge (AGS) and other microbial granules used in wastewater treatment. However, the biological mechanisms that drive granule formation remain poorly understood. Cyclic‐di‐GMP (c‐di‐GMP) is a well‐established second messenger that regulates biofilm formation, suggesting it may be used to enhance microbial granulation. Mycobacterium smegmatis mc 2 155, a nonpathogenic model bacterium for Mycobacterium tuberculosis , naturally forms granules. Unlike other bacteria, M. smegmatis carries a single c‐di‐GMP modulating gene, dcpA , that encodes an enzyme with both diguanylate cyclase (DGC) and phosphodiesterase (PDE) activities; this genetic simplicity offers a unique opportunity to examine the role of c‐di‐GMP in granulation. Here, we generated and studied three engineered M. smegmatis strains overexpressing dcpA , dcpA ∆EAL, or dcpA D192A/E193A, the latter two of which are defective in either PDE or DGC activity, respectively. Using these engineered strains, we examined different forms of biofilm growth, cell morphology, plastic surface adhesion, granulation, and settleability. Results of sludge volume index and microscopy indicated that the aggregates of M. smegmatis were granules rather than flocs, and the settleability of the granules was particularly robust when the cells were grown in a carbon rich medium known to promote granulation. Engineered strains sustained stable granulation more effectively than the wildtype under a low concentration Tween‐80 treatment, which was used to induce dispersion. These results suggest that overproduction of DcpA and thus the modulated level of intracellular c‐di‐GMP enhances granulation and promotes granule persistence in M. smegmatis . Our study further demonstrates that M. smegmatis is a useful model for elucidating biological mechanisms underlying granulation, which could be leveraged to improve granular technologies for wastewater treatment.


  • Open Access

    Rv3839-Rv3840 links the endogenous heme biosynthesis pathway with Mycobacterium tuberculosis adaptation to nitric oxide and iron limitation stress

    by Natalia F. Quirk, Kate N. Gregory, Yasu S. Morita, Shumin Tan

    During infection, Mycobacterium tuberculosis (Mtb) encounters multiple environmental stressors, including nitric oxide (NO) and iron limitation, and an ability to mount an integrated response is essential for the bacterium’s adaptation and continued survival. Iron-containing prosthetic groups in key enzymes are critical for Mtb sensing and detoxification of NO, and there is significant overlap between NO- and low iron-responsive genes. However, how Mtb adapts to these two stressors concurrently is largely unknown. Here, we find that exposure to NO globally augments expression of low iron-responsive genes and vice versa, with a two gene operon, rv3839-rv3840, among the most highly upregulated. Deletion of rv3839-rv3840 resulted in increased growth under prolonged iron limitation and early exit of Mtb from an adaptive state of growth arrest induced upon exposure to NO/low iron. ∆ rv3839-rv3840 Mtb exhibited an elongated cell morphology compared to wild type Mtb in NO/low iron conditions, indicating effects of this operon on cell growth and division under stress conditions, with Rv3839 as the key driver of this phenotype. Coproporphyrin III tetramethyl ester (TMC), a modified precursor molecule in the endogenous Mtb heme biosynthesis pathway, was found to accumulate in ∆ rv3839-rv3840 Mtb under iron limiting conditions. Further, intrabacterial heme levels were increased in ∆ rv3839-rv3840 Mtb under NO stress and iron limitation. Together, these findings reveal Rv3839-Rv3840 as proteins involved in the downregulation of heme biosynthesis under NO stress and iron limitation, and highlight the link between Mtb growth control in response to NO/low iron and endogenous heme biosynthesis.

  • Open Access

    Rv3839-Rv3840 links the endogenous heme biosynthesis pathway with Mycobacterium tuberculosis adaptation to nitric oxide and iron limitation stress

    by Natalia F. Quirk, Kate N. Gregory, Yasu S. Morita, Shumin Tan

    During infection, Mycobacterium tuberculosis (Mtb) encounters multiple environmental stressors, including nitric oxide (NO) and iron limitation, and an ability to mount an integrated response is essential for the bacterium’s adaptation and continued survival. Iron-containing prosthetic groups in key enzymes are critical for Mtb sensing and detoxification of NO, and there is significant overlap between NO- and low iron-responsive genes. However, how Mtb adapts to these two stressors concurrently is largely unknown. Here, we find that exposure to NO globally augments expression of low iron-responsive genes and vice versa, with a two gene operon, rv3839-rv3840, among the most highly upregulated. Deletion of rv3839-rv3840 resulted in increased growth under prolonged iron limitation and early exit of Mtb from an adaptive state of growth arrest induced upon exposure to NO/low iron. Δ rv3839-rv3840 Mtb exhibited an elongated cell morphology compared to wild type Mtb in NO/low iron conditions, indicating effects of this operon on cell growth and division under stress conditions, with Rv3839 as the key driver of this phenotype. Coproporphyrin III tetramethyl ester (TMC), a modified precursor molecule in the endogenous Mtb heme biosynthesis pathway, was found to accumulate in Δ rv3839-rv3840 Mtb under iron limiting conditions. Further, intrabacterial heme levels were increased in Δ rv3839-rv3840 Mtb under NO stress and iron limitation. Together, these findings reveal Rv3839-Rv3840 as proteins involved in the downregulation of heme biosynthesis under NO stress and iron limitation, and highlight the link between Mtb growth control in response to NO/low iron and endogenous heme biosynthesis. IMPORTANCE: Slowed growth is a physiologic adaptation to key environmental cues important for survival of Mycobacterium tuberculosis (Mtb) in the host. Nitric oxide (NO) is one such signal, but while regulation of NO response by the DosRS(T) two-component system is well-studied, NO stress also provokes a broad transcriptional response outside of DosRS(T) regulation that overlaps with the transcriptional response to iron limitation. Here, we show that Rv3839-Rv3840 contribute to Mtb maintenance of NO and low iron-induced growth arrest and find that this inability to maintain growth arrest is connected to dysregulation of the endogenous heme biosynthetic pathway. Little is known about regulation of endogenous heme biosynthesis in Mtb and its role in Mtb survival under stress conditions, and our results reveal a previously unknown interplay between NO and iron limitation response regulation and heme homeostasis.

  • Open Access

    Overexpression of a Gene That Modulates Cyclic-di-GMP Enhances Granulation in Mycobacterium smegmatis

    by Tiffany Lam, Samantha J. Belculfine, Joseph G. Gikonyo, Jeffrey J. Kane, Chul Park, Yasu S. Morita

    Granulation is a complex microbial-aggregation process essential for forming aerobic granular sludge (AGS) and other microbial granules used in wastewater treatment. However, the biological mechanisms that drive granule formation remain poorly understood. Cyclic-di-GMP (c-di-GMP) is a well-established second messenger that regulates biofilm formation, suggesting it may be used to enhance microbial granulation. Mycobacterium smegmatis , a nonpathogenic model bacterium for Mycobacterium tuberculosis , naturally forms granules. Because M. smegmatis carries a single c-di-GMP modulating gene, dcpA , that encodes an enzyme with both diguanylate cyclase (DGC) and phosphodiesterase (PDE) activities, it offers a unique opportunity to examine the role of c-di-GMP in granulation. Here, we generated and studied two engineered M. smegmatis strains overexpressing dcpA or dcpA ΔEAL, the latter of which is defective in PDE activity. Using these engineered strains, we examined different forms of biofilm growth, cell morphology, plastic surface adhesion, granulation, and settleability. Results of sludge volume index and microscopy indicated that the aggregates of M. smegmatis were granules rather than flocs, and the settleability of the granules was particularly robust when the cells were grown in a carbon rich medium known to promote granulation. Engineered strains sustained stable granulation more effectively than the wildtype under low concentration Tween-80 treatment, which was used to induce dispersion. These results suggest that overproduction of DcpA and thus the modulated level of intracellular c-di-GMP enhances granulation and promotes granule persistence in M. smegmatis . Our study further demonstrates that M. smegmatis is a useful model for elucidating biological mechanisms underlying granulation, which could be leveraged to improve granular technologies for wastewater treatment.

  • Open Access

    Compartmentalized cell envelope biosynthesis in Mycobacterium tuberculosis

    by Julia Puffal, Ian L. Sparks, James R. Brenner, Xuni Li, John D. Leszyk, Jennifer M. Hayashi, Scott A. Shaffer, Yasu S. Morita

    The inner membrane domain (IMD) is a metabolically active and laterally discrete membrane domain initially discovered in Mycobacterium smegmatis . The IMD correlates both temporally and spatially with the polar cell envelope elongation in M. smegmatis . Whether or not a similar membrane domain exists in pathogenic species remains unknown. Here, we show that the IMD is a conserved membrane structure found in Mycobacterium tuberculosis . We used two independent approaches, density gradient fractionation of membrane domains and visualization of IMD-associated proteins through fluorescence microscopy, to determine the characteristics of the plasma membrane compartmentalization in M. tuberculosis . Proteomic analysis revealed that the IMD is enriched in metabolic enzymes that are involved in the synthesis of conserved cell envelope components such as arabinogalactan and phosphatidylinositol mannosides. Using a fluorescent protein fusion of IMD-associated proteins, we demonstrated that this domain is concentrated in the subpolar region of the rod-shaped cells, where active cell envelope biosynthesis is taking place. Proteomic analysis further revealed the enrichment of enzymes involved in synthesis of phthiocerol dimycocerosates and phenolic glycolipids in the IMD. We validated the IMD association of two enzymes, α1,3-fucosyltransferase and fucosyl 4- O -methyltransferase, which are involved in the final maturation steps of phenolic glycolipid biosynthesis. Taken together, these data indicate that functional compartmentalization of membrane is an evolutionarily conserved feature found in both M. tuberculosis and M. smegmatis , and M. tuberculosis utilizes this membrane location to enrich biosynthetic enzymes for its surface-exposed lipid virulence factors. IMPORTANCE: M. tuberculosis remains an important public health threat, with more than one million deaths every year. The pathogen’s ability to survive in the human host for decades highlights the importance of understanding how this bacterium regulates and coordinates its metabolism, cell envelope elongation, and growth. The IMD is a membrane structure that associates with the subpolar growth zone of actively growing mycobacterial cell, but its existence is only known in a non-pathogenic model, M. smegmatis . Here, we demonstrated the presence of the IMD in M. tuberculosis , making the IMD an evolutionarily conserved plasma membrane compartment in mycobacteria. Furthermore, our study revealed that the IMD may function as the factory for synthesizing phenolic glycolipids, virulence factors produced by slow-growing pathogenic species.


  • Open Access

    Loss of Ag85A disrupts plasma membrane domains and promotes free mycolic acid accumulation in mycobacteria

    by Takehiro Kado, Jake Jordan, Joel S. Freundlich, M. Sloan Siegrist, Yasu S. Morita

    Summary: The mycomembrane of mycobacteria, composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress, yet its underlying synthesis mechanisms remain incompletely understood. This study investigates the role of Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using Δ Ag85A deletion mutants, we combined microscopy, biochemical assays, thin-layer chromatography, and lipid analysis to evaluate changes in membrane structure, chemical accumulation, and lipid composition. Ag85A deletion leads to altered plasma membrane domain organization, increased chemical accumulation, changes in cell envelope lipid composition. Unexpectedly, lipid analysis revealed accumulation—not depletion—of mycolic acids in the mutant, suggesting that increased permeability is not directly due to mycolic acid loss. These findings highlight a novel link between mycomembrane composition and plasma membrane domain stability. Our study not only advances understanding of mycobacterial cell envelope architecture but also identifies potential targets for enhancing drug penetration in resistant mycobacterial infections. Significance: The unique cell envelope of mycobacteria is central to survival, enabling it to resist immune defenses and antibiotic treatment. In this study, we reveal a novel function of Ag85A, a synthase of outmost layer of mycobacteria beyond its known role in mycolyltransferase activity: it is essential for the formation of plasma membrane domains that orchestrate cell envelope synthesis. By structuring plasma membrane domains, Ag85A contributes directly to the resilience of the cell envelope, reinforcing mycobacterial survival mechanisms under hostile conditions. Our findings provide a pivotal insight into mycobacterial cell biology, with broad implications for therapeutic development. Disrupting Ag85A-dependent membrane domain formation could weaken the protective cell envelope, offering a promising approach to enhance current treatments.


  • Open Access

    Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE

    by Yaqi Liu, Chelsea M. Brown, Nuno Borges, Rodrigo N. Nobre, Satchal Erramilli, Meagan Belcher Dufrisne, Brian Kloss, Sabrina Giacometti, Ana M. Esteves, Cristina G. Timóteo, et al.

    Tuberculosis (TB), a leading cause of death among infectious diseases globally, is caused by Mycobacterium tuberculosis (Mtb). The pathogenicity of Mtb is largely attributed to its complex cell envelope, which includes a class of glycolipids called phosphatidyl-myo-inositol mannosides (PIMs). These glycolipids maintain the integrity of the cell envelope, regulate permeability, and mediate host-pathogen interactions. PIMs comprise a phosphatidyl-myo-inositol core decorated with one to six mannose residues and up to four acyl chains. The mannosyltransferase PimE catalyzes the transfer of the fifth PIM mannose residue from a polyprenyl phosphate-mannose (PPM) donor. This step contributes to the proper assembly and function of the mycobacterial cell envelope; however, the structural basis for substrate recognition and the catalytic mechanism of PimE remain poorly understood. Here, we present the cryo-electron microscopy (cryo-EM) structures of PimE from Mycobacterium abscessus in its apo and product-bound form. The structures reveal a distinctive binding cavity that accommodates both donor and acceptor substrates/products. Key residues involved in substrate coordination and catalysis were identified and validated via in vitro assays and in vivo complementation, while molecular dynamics simulations delineated access pathways and binding dynamics. Our integrated approach provides comprehensive insights into PimE function and informs potential strategies for anti-TB therapeutics.


  • Open Access

    Effective killing of Mycobacterium abscessus biofilm by nanoemulsion delivery of plant phytochemicals

    by Casey Albano, Ahmed Nabawy, Wyatt C. Tran, Malavika Prithviraj, Takehiro Kado, Muhammad Aamir Hassan, Jessa Marie V. Makabenta, Vincent M. Rotello, Yasu S. Morita

    Mycobacterium is an acid-fast, aerobic, non-motile, and biofilm-forming bacterium. The increasing prevalence of mycobacterial infections makes it necessary to find new methods to combat the resistance of bacteria to conventional antibiotics. Mycobacterium abscessus is an emerging pathogen that is intrinsically drug resistant due to several factors, including an impermeable cell envelope, drug efflux pumps, target-modifying enzymes, and the ability to form thick, robust biofilms. Phytochemicals are promising antimicrobials; however, their poor solubility in water and their inability to penetrate biofilms render them inefficient in killing bacterial biofilms. In this study, we demonstrate the efficacy of polymer-stabilized phytochemical nanoemulsions in killing M. abscessus biofilms. These nanoemulsions improve the solubility and stability of the phytochemicals and enable biofilm penetration and eradication. We show that the phytochemical emulsions effectively eliminated M. abscessus in an in vitro biofilm model and killed non-replicating persister cells in the Wayne hypoxia model. These nanoemulsions were also effective in vivo in a wound infection model. These findings demonstrate the potential of polymer-stabilized phytochemical nanoemulsions as a promising alternative to conventional antibiotics for the treatment of mycobacterial infections. IMPORTANCE: Mycobacterium abscessus is among the opportunistic bacterial pathogens that cause nontuberculous mycobacterial diseases. The infection caused by M. abscessus is difficult to treat because the bacterium is resistant to many of the currently available antibiotics, limiting chemotherapeutic strategies. Furthermore, it forms biofilms in clinically relevant settings, making the infection difficult to treat. Many phytochemicals have potent antimicrobial activities, but their hydrophobicity limits clinical applications. In this study, we tested a new drug delivery strategy where hydrophobic plant phytochemicals were emulsified with a biodegradable nanosponge. We show that the emulsification makes phytochemicals such as carvacrol and eugenol more effective against M. abscessus biofilms. We further demonstrate that nanoemulsified phytochemicals can kill hypoxia-induced dormant M. abscessus and effectively improve skin wound infection in mice. Our data pave the way to use phytochemical nanosponge as a platform to create synergy by combining other antimycobacterial drugs.